The Community’s strategy is to vaccinate well, not at any speed

The Community’s strategy is to vaccinate well, not at any speed

Until now, the drug known as ‘plitidepsin’ (commercially sold as Aplidin) was used in cancer research and was a powerful antiviral that now takes on enormous importance. Thanks to the study published in the journal Science, this product from the Spanish company Pharmamar has achieved a 99% reduction in the viral loads in the lungs of the animals with which they have worked in the laboratory.

Jan 26, 2021 at 13:21 CET

D. Cruz (@DCruzPeriodista)

"The antiviral activity of plitidepsin against SARS-CoV-2 occurs with the inhibition of the known target eEF1A", exposes the article of the aforementioned publication, adding that in the tests carried out ‘in vitro’ it was found that it had antiviral potential: "In two different animal models of SARS-CoV-2 infection, the test demonstrated a reduction in viral replication, which resulted in a 99% decrease in viral loads in the lung of those animals that were treated with plitidepsin".

According to the study, this drug blocks the protein eEF1A, located inside human cells and used by SARS-CoV-2 to reproduce easily and infect nearby cells. This is how Covid-19 develops in our body, and PharmaMar would have a powerful drug to stop this evolution in its tracks if clinical trials in humans are successful, which have yet to be approved by regulatory bodies.

The coronavirus vaccine, be it the one from Pfizer, Moderna or AstraZeneca, does not give you immunity the instant you receive the first dose: it takes two to fully immunize, and even then, they are recommended between 7 and 14 days after receiving the second puncture to be considered as a person 1xbet casino complaints who cannot get Covid-19, and if doing so, there is a 95% chance that it will be done asymptomatically or with a much milder clinical picture (that is the percentage of effectiveness promoted ).

Jan 26, 2021 at 18:59 CET

D. Cruz (@DCruzPeriodista)

After this brief explanation of how the Covid-19 vaccine works, we echo a news item published in Las Provincias that points out that an elderly resident of the geriatic Viver, located in the homonymous town of the province of Castellón, has died of coronavirus after you have received the two corresponding doses of the vaccine. The contagion would have occurred after the first puncture, received on December 29.

The second dose was given on January 19, but he died on January 24, just five days later, from complications derived from the coronavirus. As Fernando Simón, epidemiologist and director of the CCAES, has explained on several occasions, neither receiving the vaccine offers you complete immunity, nor does it allow you to say that you cannot be infected until several weeks after the last dose.

The coronavirus continues to advance relentlessly and yesterday the largest day of infections was recorded in Spain, but despite this there are still people who follow "going" of the subject and turning a deaf ear to the recommendations and obligations to which the authorities are now subject to the entire country.

Jan 22, 2021 at 12:17 PM CET

Josep Carceller @JosepCarceller

Many users of social networks have denounced the party that took place last night at the Teatro Barceló nightclub in Madrid, although it could have been avoided if the authorities had heeded the announcement since it was advertised in this way from the official Twitter account :

The session that we have prepared next Thursday, January 21, you cannot miss. We will have as a guest as a special artist at # TeatroBarceló the well-known ???? ?????, who will make you enjoy it in a big way.&# 128293;&# 128308; ???????.https: //

– Barceló Theater (@TeatroBarcelo) January 14, 2021

Although it is a fact that no one has avoided this announced party, the social networks of the Barceló Theater continue to announce new parties with very close dates, so the authorities should show a strong hand so that the images that were seen are not repeated again last night and that many users reported on social networks. But what is it that happened that has caused such a stir? Well here you can see it:

This was last night at the TeatroBarcelo nightclub in Madrid. Very embarrassing the truth. Then people wonder why there are so many cases. # COVID19 #coronavirus #teatrobarcelo

– Armide N. Suarez Ramirez (@armisites) January 22, 2021

As you can see, in the Barceló Theater no one respected the security measures, nor was there distance, nor were masks used, and we suppose that hygiene was also conspicuous by its absence at a party in which alcohol predominated throughout the night.

Spain is already giving the second dose of the Covid-19 vaccine to health workers, staff and users of nursing homes and large dependents who received the first of them in recent weeks. Now, it is time to decide which is the next group of the population to be immunized, and Health, in conjunction with the autonomous communities, have agreed that this is formed by those over 70 years of age.

Jan 20, 2021 at 14:08 CET

D. Cruz (@DCruzPeriodista)

In total, 6.6 million people will start receiving the Covid-19 vaccine in late February or early March provided there are sufficient doses, because the biggest problem facing the European Union is a possible shortage. At the moment, Pfizer ships half of the agreed vials for a series of works at its plant in Belgium, while Moderna has marketed a very small number of vaccines. Hope is pinned on the future AstraZeneca vaccine, approved by the EMA almost certainly before January 29.

The goal for the Government is that between May and June there are 20-30 million people vaccinated, and that by early September herd immunity will be achieved with 70% of the population immune to the coronavirus. It is a difficult goal and, for the moment, unattainable at the current rate.

In March, if there are sufficient doses, the population over 70 years of age will begin to be vaccinated against Covid-19. It seems that that month is far away, but the truth is that it is very close, and there the mass vaccination campaign that was announced at the end of 2020 would really begin. Now, if you do not belong to that age group, when will it be your turn? receive the two doses necessary to be immune to the disease? This calculator will help you find out.

Jan 22, 2021 at 15:28 CET

D. Cruz (@DCruzPeriodista)

Dominika Miszewska and Álvaro Díez Gepe, students of Particle Physics and Medicine, have developed a very useful instrument under the name ‘Vaccination Schedule Calculator’ that is programmed from the data of the plan established by the Government. This roadmap divides the population into more than a dozen social groups depending on the priority they have in being immune to Covid-19, and may vary depending on the availability of vaccines from new laboratories or the lack of dose for a probable shortage.

Of course, although it is frustrating to be one of the last to be immune, it is worth reading what these young students expose on the calculator page: "We know that waiting for the vaccine can be frustrating. However, by prioritizing those at the highest risk of hospitalization and death, we can quickly start saving lives thanks to this wonderful weapon against the virus!".

Until now, the only totally effective treatment against Covid-19 has been the vaccine, that drug that seeks to induce immunity in the person to prevent them from contracting the disease, or otherwise, not suffer from such a serious clinical picture. But at Grifols they believe they could have an alternative solution: a drug that would offer such immunity against SARS-CoV-2, but immediately.

Jan 18, 2021 at 4:50 pm CET

D. Cruz (@DCruzPeriodista)

It is an anti-coronavirus immunoglobulin that would be administered subcutaneously to protect the elderly and healthcare personnel, and immunocompromised patients who cannot be vaccinated as indicated by the laboratories. One of its advantages is that it can be inoculated in health centers as soon as one of these groups tests positive for Covid-19; This would reduce the number of hospitalized patients by a large number.

Grifols will begin the clinical trial of this drug in Spain in the coming weeks, and its first results are expected to be released in the spring. This phase of the research is being led by Oriol Mitjà and Bonaventura Clotet, both professionals from Hospital Germans Trials and Pujol de Badalona, ​​who will be in charge of observing the 800 asymptomatic people who are part of the group of volunteers.

Pfizer announced this morning that for the next 3-4 weeks, delivery of coronavirus vaccines across the European Union will be delayed due to a series of works at its manufacturing center located in Belgium to improve facilities and thus ensure the new commitment reached with the supranational entity: almost doubling the number of doses purchased.

Jan 15, 2021 at 16:53 CET

D. Cruz (@DCruzPeriodista)

"The European Commission, and through it, the EU Member States, were recently informed that Pfizer will not be able to deliver the already committed volume of deliveries in the next 3-4 weeks due to modifications at the Puurs plant.", the European Union itself has informed through a statement. With this news, a total stoppage of shipments is not expected, but rather a notable reduction in the number of doses reaching the countries.

The Community’s strategy is to vaccinate well, not at any speed. That is why we have saved the second dose and that the whole process is effective.

Related Posts

× گفتگو